Anti-inflammatory mechanism of action of azithromycin in LPS-stimulated J774A.1 cells
| Autor: | Mario Hlevnjak, Krunoslav Nujić, Mihailo Banjanac, Daniela Belamarić, Vesna Munic Kos, Slaven Crnković, Vesna Eraković Haber, Mila Vrančić |
|---|---|
| Rok vydání: | 2012 |
| Předmět: |
Lipopolysaccharides
medicine.drug_class Indomethacin Anti-Inflammatory Agents Inflammation Pharmacology Biology Azithromycin Anti-inflammatory Dinoprostone Cell Line chemistry.chemical_compound Mice medicine Animals RNA Messenger chemistry.chemical_classification Arachidonic Acid Interleukin-12 Subunit p40 Interleukin-6 Tumor Necrosis Factor-alpha azithromycin inflammation J774A.1 cells LPS cytosolic phospholipase A2 Group IV Phospholipases A2 Macrophages Anti-Inflammatory Agents Non-Steroidal bacterial infections and mycoses Anti-Bacterial Agents Enzyme chemistry Mechanism of action Cell culture Prostaglandin-Endoperoxide Synthases Eicosanoids Arachidonic acid medicine.symptom Eicosanoid Production medicine.drug |
| Zdroj: | Pharmacological research. 66(4) |
| ISSN: | 1096-1186 |
| Popis: | Azithromycin is a macrolide antibiotic with well-described anti-inflammatory properties which can be attributed, at least partially, to its action on macrophages. We have previously shown, with 18 different macrolide molecules, that IL-6 and PGE₂ inhibition correlates with macrolide accumulation, as well as with their binding to phospholipids in J774A.1 cells. The present study was performed in order to substantiate the hypothesis that biological membranes are a target for macrolide anti-inflammatory activity. By analyzing the effect of azithromycin on overall eicosanoid production, we found that in LPS-stimulated J774A.1 cells, azithromycin, like indomethacin, inhibited the synthesis of all eicosanoids produced downstream of COX. Upstream of COX, azithromycin inhibited arachidonic acid release in the same way as a cPLA₂ inhibitor, while indomethacin had no effect. Further comparison revealed that in LPS-stimulated J774A.1 cells, the cPLA₂ inhibitor showed the same profile of inhibition as azithromycin in inhibiting PGE₂, IL-6, IL-12p40 and arachidonic acid release. Therefore, we propose that the anti-inflammatory activity of azithromycin in this model may be due to interactions with cPLA₂, causing inadequate translocation of the enzyme or disturbing physical interactions with its substrates. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect